Silverback Therapeutics

$0.00 (0.00%) As of 4:11 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell SBTX and other ETFs, options, and stocks.

About SBTX

Silverback Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on the proprietary ImmunoTAC technology platform to develop systemically delivered, tissue targeted therapeutics for the treatment of cancer, chronic viral infections, and other serious diseases.

CEO
Laura K. Shawver
Employees
90
Headquarters
Seattle, Washington
Founded
2016

SBTX Key Statistics

Market cap
117.39M
Price-Earnings ratio
—
Dividend yield
—
Average volume
243.04K
High today
$3.35
Low today
$3.28
Open price
$3.30
Volume
37.18K
52 Week high
$35.63
52 Week low
$2.80

SBTX Earnings

-$1.37
-$0.91
-$0.46
$0.00
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 11, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure